yr 〜
yr

Search results 3

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor : establishment and xenograft of a cell line to predict clinical efficacy

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor : establishment and xenograft of a cell line to predict clinical efficacy
Digital博士論文障害者向け資料あり
Kanemaru, Yu2020-03-23
National Diet Library
  • Subject HeadingEpithelioid glioblastoma BRAF V600E Targeted therapy P...
  • Note (General)Epithelioid glioblastoma is a rare aggressive variant ...

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity
Digital博士論文障害者向け資料あり
中島, 希群馬大学医学系研究科2019-03-22
National Diet Library
  • Subject HeadingBRAF CDKN2A/B diffuse astrocytoma epithelioid glioblastoma TERT
  • Alternative TitleEpithelioid glioblastomaはBNAF V600E変異、TERT promoter変異お...
  • Alternative TitleEpithelioid glioblastomaはBNAF V600E変異、TERT promoter変異お...

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity
Digital博士論文
中島, 希群馬大学医学系研究科2019-03-22
Available onlineOther Libraries in Japan
  • Subject HeadingBRAF CDKN2A/B diffuse astrocytoma epithelioid glioblastoma TERT
  • Alternative TitleEpithelioid glioblastomaはBNAF V600E変異、TERT promoter変異お...
  • Alternative TitleEpithelioid glioblastomaはBNAF V600E変異、TERT promoter変異お...

Reached to the end of result.